The objectives of this study were to evaluate the concentration of 8-alfa-hydroxymutilin (8α-HM) as marker residue for tiamulin (pleuromutilins group), to verify and validate an analytical method for the quantitative determination of 8-alpha-hydroxymutilin in porcine tissues (muscle and liver). Quantification of (8α-HM) was performed with liquid chromatography-tandem mass spectrometry (LC-MS/MS). This method was used to determine the residue of 8α-HM in porcine tissue after administration of Rodotet premix. In order to assess the residues in porcine tissues, an analytical method for 8-alpha-hydroxy-mutilin was verificated and validated in line with accordance of Commission Decision 2002/657/EC and VICH GL49.
INTRODUCTION
Tiamulin is a pleuromutilin antibiotic licensed for use in veterinary medicine (Anonymous, 1999) . One of the mеtabo-lites of tiamulin is 8-alpha-hydroxymutilin (8α-HM). Quantification of the analyte was performed with liquid chromatography-tandem mass spectrometry (LC-MS/ MS). Maximum residual levels (MRLs) of tiamulin have been established in Commission Regulation No 37/2010 (Anonymous, 2010 which lays down the presented marker residue for tiamulin as the sum of metabolites that may be hydrolysed to 8α-HM. The Regulation established MRLs of 100 µg.kg -1 for porcine muscle and 500 µg.kg -1 for porcine liver. The available analytical method is further used for determination of 8α-HM. It was apply for determination of drug residues in porcine tissues, which were produced as part of a residue study with Rodotet premix.
Validation procedure is performed following the requirements defined in Com-mission Decision 2002/657/EC (Anonymous, 2002) and Bioanalytical method validation. Linearity, within-and betweenrun accuracy and precision, limit of detection (LOD), limit of quantification (LOQ), specificity, applicability and practicability, carry-over on the LC-MS/MS instrument, susceptibility to interference were evaluated validation parameters are among routinely measured parameters.
The used verificated method contained a hydrolysis step (termed method A), similarly to the method developed by Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine, University of Gent (Anonymous, 2013) . The method does not use internal standard norfloxacin D 5, added from the beginning of analysis, because of the hydrolysis step which is not appropriate for this substance. The internal standard norfloxacin D 5 was added before instrumental analysis to evaluate the matrix effect only. Additionally, to determine the behaviour of 8α-HM (e.g. behaviour in matrix and freeze-thaw influence, the preparation of samples and stability of the analyte), an analytical method without hydrolysis step, described as method B, was also used.
A study was performed to evaluate the real content of 8α-HM as marker residue for tiamulin and to verify the method for quantitative determination of 8α-HM in porcine tissues (muscle and liver) developed and validated by the Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine, University of Gent for determination of 8α-HM in rabbit tissues (Anonymous, 2013) . The objectives of the study were on one hand, to determine the residue of marker compound of tiamulin in muscle and liver of pigs as part of a Biovet's residue study with Rodotet premix. On the other hand, the aim was to verify and validate an analytical method for the quantitative determination of 8-alphahydroxymutilin in porcine tissues performed in the routine practice of CLVCE as National Reference Laboratory.
MATERIALS AND METHODS
The study was performed under standardised laboratory conditions, standard operating procedures (SOPs) and special forms accompanying the SOPs for all experiments, given by Biovet. The analytical phase of the study was conducted according to the procedures described in the study plan and its amendment and observing the Principles of Good Laboratory Practice (Anonymous, 2009a) .
Chemicals and reagents
Acetonitrile (ACN), etylacetate and methanol (Labscan, Dublin, Ireland) were of p.a. and HPLC grade. Formic acid, HCl and NaOH (p.a. grade) were supplied by Merck (Darmstadt, Germany). All working solutions were prepared with deionised water (18.2 MΩ.cm resistivity) generated by ELGA system (Marlow, United Kingdom).
Standards and standard solutions
The 8-alpha-hydroxy-mutilin reference standard, stored in refrigerator, was purchase by Argus Chemicals srl (Chemical Reference Substance, Argus Chemicals srl, Italy). The assay of 8α-HM resulted in more than 90% of 8-alpha-hydroxymutilin (certificate of analysis provided by Argus Chemicals srl). Because the certificate of analysis doesn't give the exact amount of 8α-HM it was decided to set the purity on 100% to create a worst case scenario. Argus Chemicals are the only provider of 8α-HM known to Biovet. 
Equipment

Samples
The test item was stored at the test facility at ≤ -15 °C. The storage temperature was monitored continuously during the conduct of this validation study. A sufficient amount (about 100 mg) of the test item 8-alpha-hydroxymutilin as reference substance together with a certificate of analysis arrived at the test facility. The test item was added to the test systems (i.e. blank porcine tissues) by spiking an appropriate amount of a solution. The calculations were done with respect to 8α-HM since this is the marker residue of tiamulin. Homogenised blank porcine tissues were spiked with standard solutions and were used as quality control samples (QC sp). The QC spiked samples served as a control to check the acceptance of the extraction procedure and LC-MS/MS run of evaluated unknown samples, especially for the hydrolysis step. The QC samples were prepared by spiking blank tissues at MRL levels of 8α-HM.
Sample preparation procedures
Method A (Anonymous, 2006) . The term precision in this validation procedure covers the 'repeatability' or within-run precision and 'reproducibility' of between-run precision: The within-run conditions include the use of the same method on identical test material, in the same laboratory by the same operator using the same equipment within short intervals of time. The between-run conditions include the use of the same method on identical test material, in the same laboratory, but analysed on different days. The within-run and between-run precision were determined at four concentration levels per tissue. For each concentration level, analysis of 6 independently spiked samples was performed, 6 blank solvents samples and 18 blank tissues samples. It was expressed as the relative standard deviation (RSD, %). Accuracy refers to the closeness of agreement between the true value of the analyte concentration and the mean result that is obtained by applying the experimental procedure a number of times (n ≥6). Accuracy calculated as (mean concentration found -spiked concentration)/spiked concentration ×100% was determined at three concentration levels per tissue. For each concentration level, analysis of 18 independently spiked samples were performed. In this study, the LOD was determined based on three calibration curves for 8-alpha-hydroxy-mutilin and was calculated using the intercept and slope of the curves according to following equation: LOD=3×Signal/Noise. The limit of detection (LOD) (the smallest measured content from which it is possible to deduce the presence of the analyte with reasonable statistical certainty) was calculated using the intercept and slope of the curves according to following equation: LOD=3×Signal/Noise. The limit of quantification (LOQ) corresponds to the smallest measured content of an analyte above which the determination of the analyte can be made with a specified degree of accuracy and precision. Carry-over is the analyte concentration that possibly was determined in the solvent sample below the LOD level. The presence/absence of carry-over on the LC-MS/MS instrument was evaluated by injecting a blank solvent sample after the highest calibration sample.
The specificity refers to the ability of a method to distinguish between the analyte being measured and other substances. The specificity is predominantly a function of the measuring principle used. Since LC-MS/MS is used, the technique as such is already specific, since quantification is related to the molecular mass of 8-alphahydroxy-mutilin. Therefore, the specificity was demonstrated with respect to possible interferences of other endogenous compounds with the same retention time as 8-alpha-hydroxymutilin. It was evaluated by the analysis of at least 18 blank tissue sample. Applicability refers to the commodities to which the method can be applied as described or with minor modifications. Practicability is a characteristic procedure, dependent on the scope of the method. It is determined by requirements such as availability of standards, reagents and equipement, sample throughput, costs, safety. Robustness refers and relates to susceptibility to non-specific influences on the analytical results of certain experimental conditions, which can be subject to fluctuation (pH, temperature, operator e.t.c.).
This parameter, validation of hydrolysis step and stability of the method were not evaluated according to standard protocol since sufficient control measures are taken at the test facility to minimize variations by strictly following the SOP . They were evaluated on the basis of information given by Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine, Gent (Anonymous, 2013).
RESULTS
The verificated analytical method was validated according to the widely accepted above mentioned criteria. Stability data described in literature are used and no experiments were done. The following parameters were demonstrated: for method A (with hydrolysis): linearity, withinrun and between-run accuracy, within-run and between-run precision, limit of detection (LOD), limit of quantification (LOQ), carry-over on the LC-MS/MS instrument, specificity, applicability and practicability, susceptibility to interference ( Table  2) .
The method without hydrolysis (method B) was evaluated for linearity, within-run and between-run accuracy and precision, limit of quantification (LOQ), limit of detection (LOD), specificity, applicability and practicability, susceptibi-lity to interference and carry-over on the LC-MS/MS instrument.
Calibration curve linearity
The calibration curves were prepared by analysing blank porcine tissue spiked with standard solutions at levels 25, 50, 100, 150, 200, 250, 500, 750 , 1000 µg/kg 8α-HM. The concentrations were calculated against the calibration curve, using internal standard correction by linear regression. The results are shown in Tables 2, 3 and 4.
The within-run and between-run accuracy and precision were determined using blank porcine tissue spiked at 50, 100, 150 and 200 µg/kg of 8α-HM (n=9) for muscle and at 250, 500, 750 and 1000 µg/kg of 8α-HM (n=9) for liver, i.e. the accuracy and precision (expressed as within-run and between-run precision) were calculated using spiked samples at the level of ½ MRL, MRL, 1.5MRL and 2MRL. The accuracy fell within the range of -20% to +10%. The LOQ was determined by analysing spiked samples (n=17) at a level of 50 µg/kg 8α-HM. The accuracy fell within the range of -20% to +10%. The determined RSDs were also below the RSDmax value. Therefore, the LOQ was set at 50 µg/kg for all tissues examined.
The LOD data for both methods A and B are present in Tables 2 and 3. For tissue analysis using LC-MS/MS, the carry-over from one sample to another was studied by injecting mobile phase and blank solvents-sample after the highest calibrator of 250 or 1000 µg/kg. No peak was detected in the mobile phase samples The specificity was demonstrated with respect to possible interference of endogenous compounds with the same retention time as 8α-HM and norfloxacin D 5 . It was evaluated by the analysis of in-house blank tissue samples. No peaks at the retention time of 8α-HM and internal standard could be detected.
The method applied used standards, reagents and equipment that are commercially available. The method can be performed with a sample throughput that is normal for tissue analysis and at reasonable costs per sample. Only normal laboratory safety requirements have to be taken into account. The acceptance criteria for those parameters were followed.
Stability was demonstrated in solvent during storage: peak area of the test solution within -10% of the area in the reference solution; in extract during analysis (QC), acceptance criteria: cfr. within-run accuracy & precision; -in extract during storage (QC stab extr), acceptance criteria: cfr. within-run accuracy & precision; in matrix during storage (QCstab), acceptance criteria: cfr. within-run accuracy & precision".
Chromatograms of standard solutions, blank tissues samples and spiked samples are given on Fig. 1 .
DISCUSSION
In our experiments, the method was validating according to Commission Decision 2002/657/EC (Anonymous, 2002) . Several methods for determination of pleuromutilin residues in tissues with animal origin using different instrumental technices and sample preparation procedures have been published. Some of them are conducted by gas chromatography, HPLC and HPLC-MS (Markus & Scherma, 1993a; Chen et al., 2006) . The reported LOD of these methods ranged from 0.0014 ppm for HPLC-MS (Schlusener et al., 2003) and 10 ppm for HPLC (Markus & Scherma, 1993b) . The sensitivity and the specificity by GC (Markus & Scherma, 1993c ) and traditional HPLC is lower than those of LC-MS/MS analysis. The methods for determination of tiamulin marker residue 8α-HM are only few. The described verification of method characteristics was done by evaluating the obtained data of experiments with porcine tissues only, as tiamulin produced by Biovet in Bulgarian veterinary practice is used only in swine. The described data were related only to the applicability of the method for porcine tissues and we do not have data on method's application (without or with adjustment of conditions) for other matrices. Experiments with other type matrixes (chicken muscle, liver, skin and fat) are forthcoming. Practically some of the steps in verification of an analytical method are represented without comparision of data and application of analytical procedures. Related to carry-over effect for verificated LC-MS/MS method, no peak was detected in the mobile phase samples demonstrating the absence of carry-over on the instrument for both methods A and B, because of acceptance for signal below of LOD. By the analysis of in-house blank tissue samples no peaks at the retention time of 8α-HM and internal standard could be detected. The method is specific for the determination of 8-alpha-hydroxymutilin and norfloxacin D 5 with respect to the interference of endogenous compounds for both methods A and B, according to method, described by Gent team, and the data provided by Biovet from Huntigdon Life Science Ltd, England (Anonymous, 2006) . The obtained data for applicability and practicability as verification method parameters were indentical to the method used in Gent with commercially available standards, reagents and equipment. Stability testing was not done as published data were used (Anonymous, 2006) and because of the opportunities given by Anonymous (2002) .
Our method fulfilled the acceptance criteria, which, according to Knecht & Stork (1974) , required correlation coefficient >0.99.
As per VICH GL 49 (Anonymous, 2012 ) the precision for analyses carried out under repeatability conditions (withinrun): ≥ 10 µg/kg < 100 µg/kg acceptable within-run precision (repeatability), %CV, is 15 and ≥100 µg/kg acceptable withinrun precision (repeatability), % CV, is 10 %". The precision was also within the maximum RSD values, determined by Anonymous (2005) for analyses carried out under reproducibility conditions (between-run) RSDmax= 2 (1-0.5logC).
According to Anonymous (2002; 2005) the acceptance criteria for LOQ met the acceptance criteria, i.e. LOQ<MRL/2; lowest point of the calibration curve; accuracy and precision -within the ranges specified.
The requirement for specificity (Heitzman, 1994; Anonymous, 2005) was also met: no endogenous substances with the same retention time as the analyte (<LOD). Therefore, it was concluded that the method was specific for the determination of 8α-HM and norfloxacin D 5 with respect to the interference of endogenous compounds for both methods A and B. Criteria such as carry-over, applicability and practicability, were also fulfilled.
